Connect with us

Media & Technology

UA Multimedia, Inc., (OTCMKTS: UAMM) Major Move as Crypto Operator Looks to Become Just the 3rd Public Company to Own a Crypto Exchange

Published

on

UA Multimedia, Inc., (OTCMKTS: UAMM) is marching northbound with power since a brief dip after the historic run the stock made earlier this year from double zeroes to highs of $0.01625. UAMM is currently under heavy accumulation with many new investors jumping on board every day. The stock is quickly emerging as an investor favorite and is currently among the most actively searched and talked about stocks in small caps. UAMM is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – a break over recent $0.01625 highs and its blue skies ahead for UAMM. 

It’s easy-to-get excited about UAMM at current levels; the stock has a history of explosive moves running to $0.01625 earlier this year over the course of several trading sessions. The Company has virtually no debt, no convertible notes on the books and no preferred shares. UA Multimedia is making several big moves; they are currently in the process of acquiring a crypto exchange which would make UAMM just the 3rd public Company to own a crypto exchange besides Coinbase and NSAV. The Company is also looking to offer crypto trading via its own decentralized exchange. Unlike centralized exchanges such as Coinbase or Binance where the exchange function as a trusted intermediary to facilitate trades and store customers tokens, DEX trading is peer-to-peer and the users retain full custody of their cryptos via their own wallets. This is a much safter type of crypto exchange as the exchange cannot shut down taking the customers coins with it, as has happened so many times in recent years. UAMM also owns an advertising portal called MJ Circle which has seen solid growth and continues to escalate.  The platform currently has several thousand active accounts, and the number of visitors has been increasing on a steady basis.  

UAMM Stock Price, News, Charts - BenzingaUA Multimedia, Inc., (OTCMKTS: UAMM) operating out of Irvine, Califronia is a holding company and a solution provider specializing in blockchain, cryptocurrency, fintech and decentralized finance (DeFi). To err on the side of caution, management had deliberately put the development and launch of CannaMedi.com on hold since the beginning of January when Jeff Session rescinded of the Cole Memo.  Due to the recent positive development in the cannabis industry, management had resumed the preparation for the site launch, which is scheduled to take place sometime in the next quarter. 

The Company’s wholy owned subsidiary online cannabis advertising portal, MJCircle.com, specifically targets to the cannabis industry. MJ Circle allows all businesses and individuals to advertise their products and services as well as posting jobs related to the medical and recreational cannabis markets. Set up similar to Craigslist, the portal will serve as a central location for everyone to post jobs, items for sale, services offered or upcoming events. 

The growth of the advertising portal MJ Circle has been solid and continues to escalate.  The platform currently has several thousand active accounts, and the number of visitors has been increasing on a steady basis.  The Company has booked modest revenues last quarter as well as this quarter from premium services and plans to increase its marketing effort once certain regulatory, technical issues and enhancements for the site have been addressed. 

https://twitter.com/hustle2015/status/1422571158717800448

To Find out the inside Scoop on UAMM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

UAMM

Earlier this year the Company appointed Michael Lajtay as Interim Chief Executive Officer. Mr. Lajtay is currently a consultant for SupraAlgae, Inc., a manufacturer of unique soil conditioners targeted at the cannabis market.  He is also involved with cryptocurrencies in various capacities since 2014.  He has served as a cryptocurrency consultant, trainer and speaker as well as participated in numerous initial coin offerings (ICOs) and has helped launch several sophisticated mining operations.  Mr. Lajtay also has extensive business experience in the area of consumer products and automotive.  Mr. Lajtay holds a B.A. in Economics from Claremont McKenna College. 

“UA Multimedia is well positioned in the area of cannabis ancillary products and services.  With its pending expansion plan and incorporation of blockchain and cryptocurrency, the potential for growth is tremendous.  I am excited to be part of the organization and looking forward to work with the team to take the company to the next level,” commented Michael Lajtay, Presid 

On May 24 UAMM provided an update on its crypto exchange and non-fungible token (NFT) business. Specialist Crypto Exchange: The acquisition candidate crypto exchange has selected Georgia as the a new country to redomicile. Certain certification has taken longer than expected to obtained. With the most time consuming part completed, the company is now focusing on finalizing the registration process and expected to take on new business sometime in June. The exchange will offer competitive listing fees allowing entities to easily list and offer their tokens for sale. The exchange will also offer marketing and capital raising services. The platform is non-custodial and will interface with selected popular digital wallets to forward proceeds directly to the wallet owners using smart contracts. The two companies have been lining up new listing candidates and will provide more details about the offerings once the business is operational. 

Decentralized Exchange (DEX): UA is also considering to offer crypto trading via its own decentralized exchange. Unlike centralized exchanges such as Coinbase or Binance where the exchange function as a trusted intermediary to facilitate trades and store customers tokens, DEX trading is peer-to-peer and the users retain full custody of their cryptos via their own wallets. As cryptocurrency trading gain more popularity, decentralized exchanges are becoming more user friendly and common. DEXs are also less prone to hacking since they dont have custody of the customers funds. Another attractive feature of decentralized exchanges is privacy. Because they are not under any central control, there is often no registration requirements where sensitive user information must be provided. 

Non-Fungible Token (NFT) 

The software development of the NFT marketplace is making steady progress. The marketplace will initially accept listing of digital arts but will eventually be expanded to other areas of collectibles such as music, gaming and sports. The platform will also aim to make NFT transactions more efficient and less expensive. Using social tools and promotion services, creators can improve the NFTs selling probability. To address the prohibitive high fees often faced with NFT transactions on the Ethereum blockchain, the marketplace will also interface with Binance blockchain where NFT transaction fees will be negligible. The dual interface will allow creators and collectors to transact on both blockchains while keeping a single profile and collection on a single platform. The platform is scheduled to go live by the end of this quarter. Incremental updates will be provided as progress is made. 

ERC-20 Utility Token: The Company is planning a partnership with a non-US entity to offer ERC-20 utility tokens. The tokens can be earned from community participation or marketplace usage. They can also be traded, swapped or used to purchase NFTs. Additional information about the tokens and trading will be forthcoming. Cryptocurrency trading and NFT activities have been growing rapidly, said Michael Lajtay, CEO of UA Multimedia. We are looking forward to capture these market shares with our advanced blockchain solutions which we believe will provide more potential profit opportunities for crypto traders and better experience for NFT market participants. 

https://twitter.com/hustle2015/status/1422573249955778565

For More on UAMM Subscribe Right Now!

UAMM is marching northbound with power since a brief dip after the historic run the stock made earlier this year from double zeroes to highs of $0.01625. UAMM is currently under heavy accumulation with many new investors jumping on board every day. The stock is quickly emerging as an investor favorite and is currently among the most actively searched and talked about stocks in small caps. UAMM is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – a break over recent $0.01625 highs and its blue skies ahead for UAMM.  It’s easy-to-get excited about UAMM at current levels; the stock has a history of explosive moves running to $0.01625 earlier this year over the course of several trading sessions. The Company has virtually no debt, no convertible notes on the books and no preferred shares. UA Multimedia is making several big moves; they are currently in the process of acquiring a crypto exchange which would make UAMM just the 3rd public Company to own a crypto exchange besides Coinbase and NSAV. The Company is also looking to offer crypto trading via its own decentralized exchange. Unlike centralized exchanges such as Coinbase or Binance where the exchange function as a trusted intermediary to facilitate trades and store customers tokens, DEX trading is peer-to-peer and the users retain full custody of their cryptos via their own wallets. This is a much safter type of crypto exchange as the exchange cannot shut down taking the customers coins with it, as has happened so many times in recent years. UAMM also owns an advertising portal called MJ Circle which has seen solid growth and continues to escalate.  The platform currently has several thousand active accounts, and the number of visitors has been increasing on a steady basis. We will be updating on UAMM on a daily basis so make sure you are subscribed to microcapdaily.com so you know what is going on with UAMM.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in UAMM either long or short and we have not been compensated for this article.

Continue Reading
2 Comments

2 Comments

  1. Stam

    December 17, 2021 at 9:43 am

    Obviously, the writer of this article doesn’t have a proofreader. Share price today is $0.03 +/-, yet you write over and over again about the amazing “recent high” of $0.0165 and how it will no doubt get there again. Amazing.

    I know it will probably drop down there long before it reaches $0.165, but that isn’t the point. This a very bad mistake when it comes to attempting to be a “reliable” source for stock market information. You get my point.

    • Boe Rimes

      December 19, 2021 at 8:35 pm

      Did you look at the date the article was written? its at the top of the article.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum

Published

on

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc. chose a lead candidate.

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc., a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, chose a lead candidate aimed at an undisclosed tumor-associated antigen for further development towards clinical settings.

GAMMABODY™ PLATFORM

LAVA primarily focuses on revolutionizing cancer therapy by developing its Gammabody™ platform. This platform enables them to create bispecific gamma delta T cell engagers that can activate a specific subset of gamma-delta T cells called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells. By utilizing this approach, they aim to enhance the natural recognition of tumors, guide Vγ9Vδ2 T cells to target the tumor cells directly and trigger a cascade of immune responses.

To Discover the Inside Scoop on LVTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What sets their Gammabody™ drug candidates apart is their exceptional performance and safety profiles observed in preclinical studies. Compared to other bispecific T cell engager approaches, their candidates have demonstrated superior efficacy and preferred targeting tumor cells. This targeted approach has the potential to minimize toxicity in healthy tissues.

In May 2020, LAVA entered into a research collaboration and license agreement with Janssen, a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration aimed to discover and develop novel bispecific antibody-based gamma delta T cell engagers for cancer treatment. The agreement was facilitated by Johnson & Johnson Innovation, emphasizing their commitment to fostering innovation in the field.

As part of the collaboration, LAVA had the opportunity to receive potential milestone payments and royalties based on the successful development, regulatory approvals, and commercialization of the candidates. This incentivized LAVA to actively pursue the discovery and advancement of promising lead candidates. 

The collaboration represents a remarkable milestone many early-stage biotech companies aspire to achieve. Partnering with a program brings numerous benefits, including reduced risk of dilution through milestone payments as the trials advance and streamlined commercialization once the product receives approval.

Under the terms of the agreement, Janssen will assume responsibility for the selected candidate’s future clinical development, manufacturing, and commercialization. This includes bearing the costs and expenses associated with these activities.

Stephen Hurly, LAVA Therapeutics’s president and chief executive officer, expressed satisfaction with Janssen’s selection of a lead candidate for clinical studies. He emphasized LAVA’s pioneering role in developing gamma-delta bispecific antibodies through their proprietary Gammabody platform. This platform and LAVA’s extensive expertise in bispecific antibody development position them at the forefront of advancing novel therapies for cancer patients.

In summary, LAVA Therapeutics’ collaboration with Janssen has reached a significant milestone in selecting a lead candidate for further development toward clinical studies. This progress underscores LAVA’s dedication to leveraging its Gammabody platform and expertise in bispecific antibody development to revolutionize cancer treatment.

We will update you on LVTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Continue Reading

Featured

Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI

Published

on

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com.

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com. The implementation of this innovative AI tool, powered by chatGPT-style Large Language Models (LLMs), has resulted in a surge of 105% in the company’s stock price and sparked tons of investor interest. The company has a 3.28M float and, at the time of writing, has traded 20x that amount, with a colossal 60M shares exchanging hands.

Revolutionizing User Experience and Driving Stock Surge

With the integration of AI search on MightyDeals.com, customers can now use natural language to describe the products they seek, simplifying the buying process. The AI tool utilizes contextual understanding and description analysis of hundreds of active deals to generate instant search results based on users’ queries. By enhancing the user experience, Onfolio Holdings anticipates increased user return rates, higher site interaction rates, and elevated revenues for MightyDeals.com. This groundbreaking development has attracted positive attention, significantly increasing Onfolio Holdings’ stock price.

To Discover the Inside Scoop on ONFO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Evaluating Financial Performance

While the stock surge indicates investor enthusiasm, assessing Onfolio Holdings’ financial performance is crucial for comprehensive investment analysis. The positive earnings growth of +44.44% and revenue growth of +22.74% contribute to the company’s optimistic outlook. However, investors should be cautious of the negative net profit margin of -190.75% and the lack of available price/book ratio data. Monitoring the company’s financial performance leading up to the next reporting date on August 30, 2023, is advised to understand its profitability and overall stability better.

Investment Outlook and Future Prospects

Considering the stock surge and optimistic price forecasts, Onfolio Holdings has promising prospects. Analysts offer a median target price of $3.00 for the company’s stock, signaling an expectation of significant growth within the next 12 months. However, it is essential to note that Onfolio Holdings operates at a loss. Investors should thoroughly evaluate the company’s long-term growth potential and weigh the potential returns against the inherent risks before making investment decisions.

About MightyDeals.com

Mighty Deals is a free daily deals website aimed at creative professionals focusing on products and services for web designers and developers. The site offers fantastic deals on quality fonts, templates, apps, add-ons, plug-ins, ebooks, icons, and more. The site provides discounts on packages which usually range between 50%-97% off but are only available for a limited time. MightyDeals.com boasts an exceptional return rate from its users and is one of Onfolio Holdings’ highest revenue-generating subsidiaries.

About Onfolio Holdings Inc.

Onfolio acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires firms that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by our existing team or have strong management teams largely in place. The Company excels at finding acquisition opportunities where the seller has not fully optimized their business. Onfolio’s experience and skillset allow it to add increased value to these existing businesses.

Conclusion

Onfolio Holdings’ introduction of the generative AI search function for MightyDeals.com has increased the company’s stock price, reflecting the market’s positive response to this innovative technology. The enhanced user experience and the potential for increased revenues have positioned Onfolio Holdings as a leader in the tech industry. However, investors must carefully consider the company’s financial performance and evaluate its long-term growth potential before making investment decisions. Monitoring the company’s performance to the next reporting date will provide valuable insights into its financial health and stability.

We will update you on ONFO when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by James from Pixabay

Continue Reading

Featured

Enveric Biosciences (NASDAQ: ENVB) Pioneering the Future of Anxiety Disorder Treatment

Published

on

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news.

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news. The United States Patent and Trademark Office has granted them a notice of allowance for their patent application concerning a groundbreaking chemical compound called EB-373. This compound is being developed to address the treatment of anxiety disorders.

The forthcoming patent, titled “C4-Carbonothioate-Substituted Tryptamine Derivatives and Methods of Using,” encompasses claims for the composition of matter of a family of revolutionary prodrug derivatives of psilocin. Enveric’s lead product candidate, EB-373, stands out among these derivatives. A Notice of Allowance signifies that the USPTO has determined that a patent should be granted based on the submitted application.

To Discover the Inside Scoop on ENVB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Enveric’s commitment to innovation extends beyond EB-373. They have also submitted additional patent applications to the USPTO, exploring psilocin prodrugs with unique crystalline molecular structures. Moreover, they have taken proactive steps to pursue global coverage of the EVM201 and EVM301 Series through companion Patent Cooperation Treaty and non-US national patent applications. Encouragingly, positive International Search Reports and written opinions have been received under the Patent Cooperation Treaty for most of these applications.

Joseph Tucker, Ph.D., Enveric’s director and CEO, underlined the significance of the USPTO’s favorable decision concerning their lead candidate, EB-373. He highlighted the innovative designs of their psilocin prodrugs within the EVM201 series, differentiating them from conventional counterparts like psilocybin. These novel designs hold the potential to deliver more rapid therapeutic effects, precise control, and reduced gastrointestinal side effects. Tucker emphasized that securing a robust intellectual property portfolio for their new chemical entity prodrugs is pivotal to Enveric’s value proposition and integral to their business strategy of developing cutting-edge small-molecule therapeutics to address mental health disorders.

We will update you on ENVB when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gino Crescoli from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.